Cellebrite (CLBT) Director Dafna Gruber Receives RSU Award

What Happened
Dafna Gruber, a director of Cellebrite DI Ltd. (CLBT), received an award of 15,190 restricted share units (RSUs) on September 17, 2026. The RSUs were granted at a grant price of $0.00 (total reported value $0) and represent contingent rights to receive one ordinary share per RSU upon settlement.

Key Details

• Transaction date: 2026-09-17; Transaction type: Award/Grant (Code A)
• Amount: 15,190 RSUs; grant price: $0.00; reported cash value at grant: $0
• Vesting/note: Footnote F1 — RSUs will vest on September 17, 2027; each RSU equals one ordinary share upon settlement
• Shares owned after transaction: not specified in the filed Form 4
• Filing timeliness: filing date equals transaction date (appears timely); no 10b5-1 plan, tax withholding, or sale noted in this filing

Context
RSUs are a form of equity compensation that typically vest over time and convert into actual shares only upon vesting/settlement. Grants like this are routine compensation for directors and do not by themselves indicate buying or selling sentiment. For investors, vested RSUs increase insider exposure to company stock once settled, but until vesting they are contingent and not tradeable.